ZIRABEV (bevacizumab-bvzr) injection, for intravenous use
Bevacizumab injection products are used in combination with atezolizumab to treat hepatocellular carcinoma (HCC) that has spread or cannot be removed by surgery in people who have not previously not received chemotherapy.